Moxifloxacin, Ofloxacin, Sparfloxacin, and Ciprofloxacin against Mycobacterium tuberculosis: Evaluation of In Vitro and Pharmacodynamic Indices That Best Predict In Vivo Efficacy

Members of the fluoroquinolone class are being actively evaluated for inclusion in tuberculosis chemotherapy regimens, and we sought to determine the best in vitro and pharmacodynamic predictors of in vivo efficacy in mice. MICs for Mycobacterium tuberculosis H37Rv were 0.1 mg/liter (sparfloxacin [S...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Shandil, Radha K., Jayaram, Ramesh, Kaur, Parvinder, Gaonkar, Sheshagiri, Suresh, B. L., Mahesh, B. N., Jayashree, R., Nandi, Vrinda, Bharath, Sowmya, Balasubramanian, V.
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology 2007
Sujets:
Experimental Therapeutics
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC1797767/
https://ncbi.nlm.nih.gov/pubmed/17145798
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00414-06
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires